SEK 51.8
(1.77%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 3.11 Billion SEK | 40.09% |
2022 | 2.17 Billion SEK | 0.66% |
2021 | 2.16 Billion SEK | 84.02% |
2020 | 1.1 Billion SEK | -37.84% |
2019 | 1.92 Billion SEK | 99.46% |
2018 | 2.02 Billion SEK | -23.63% |
2017 | 1.06 Billion SEK | 9.98% |
2016 | 1.13 Billion SEK | -0.09% |
2015 | 1.05 Billion SEK | 24.5% |
2014 | 950.4 Million SEK | -1.32% |
2013 | 858.8 Million SEK | 5.26% |
2012 | 873.8 Million SEK | 14.0% |
2011 | 757 Million SEK | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 776 Million SEK | 4.72% |
2024 Q3 | 1.03 Billion SEK | 32.86% |
2024 Q1 | 741 Million SEK | 7.86% |
2023 Q2 | 729 Million SEK | 9.13% |
2023 Q1 | 668 Million SEK | 18.65% |
2023 Q3 | 950 Million SEK | 30.32% |
2023 FY | - SEK | 40.09% |
2023 Q4 | 687 Million SEK | -27.68% |
2022 FY | - SEK | 0.66% |
2022 Q4 | 563 Million SEK | -16.59% |
2022 Q3 | 675 Million SEK | 39.75% |
2022 Q2 | 483 Million SEK | -3.4% |
2022 Q1 | 500 Million SEK | -12.74% |
2021 Q1 | 492 Million SEK | 278.26% |
2021 Q2 | 493 Million SEK | 0.2% |
2021 Q3 | 641 Million SEK | 30.02% |
2021 Q4 | 573 Million SEK | -10.61% |
2021 FY | - SEK | 84.02% |
2020 Q3 | 567 Million SEK | 22.73% |
2020 Q4 | -276 Million SEK | -148.68% |
2020 FY | - SEK | -37.84% |
2020 Q1 | 497 Million SEK | -7.79% |
2020 Q2 | 462 Million SEK | -7.04% |
2019 Q1 | 526 Million SEK | 97.0% |
2019 Q2 | 390 Million SEK | -25.86% |
2019 Q3 | 580 Million SEK | 48.72% |
2019 FY | - SEK | 99.46% |
2019 Q4 | 539 Million SEK | -7.07% |
2018 FY | - SEK | -23.63% |
2018 Q4 | 267 Million SEK | -22.16% |
2018 Q3 | 343 Million SEK | 91.62% |
2018 Q2 | 179 Million SEK | -41.5% |
2018 Q1 | 306 Million SEK | -17.52% |
2017 Q2 | 265 Million SEK | -15.61% |
2017 FY | - SEK | 9.98% |
2017 Q3 | 374 Million SEK | 41.13% |
2017 Q4 | 371 Million SEK | -0.8% |
2017 Q1 | 314 Million SEK | -1.88% |
2016 Q1 | 228 Million SEK | 68.89% |
2016 FY | - SEK | -0.09% |
2016 Q3 | 373 Million SEK | 45.14% |
2016 Q2 | 257 Million SEK | 12.72% |
2016 Q4 | 320 Million SEK | -14.21% |
2015 FY | - SEK | 24.5% |
2015 Q4 | 135 Million SEK | -64.57% |
2015 Q1 | 222 Million SEK | -2.63% |
2015 Q2 | 221 Million SEK | -0.45% |
2015 Q3 | 381 Million SEK | 72.4% |
2014 Q3 | 331 Million SEK | 0.0% |
2014 FY | - SEK | -1.32% |
2014 Q4 | 228 Million SEK | -31.12% |
2013 FY | - SEK | 5.26% |
2012 FY | - SEK | 14.0% |
2011 FY | - SEK | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Ambea AB (publ) | 2.28 Billion SEK | -36.563% |
Humana AB (publ) | 457 Million SEK | -581.619% |
ProstaLund AB (publ) | -16.57 Million SEK | 18896.766% |